Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

VBI Vaccines Q3 EPS $(0.38) Misses $(0.14) Estimate, Sales $6.62M Miss $13.25M Estimate

Author: Benzinga Newsdesk | November 14, 2023 05:54pm
VBI Vaccines (NASDAQ:VBIV) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.14) by 171.43 percent. This is a 87.33 percent increase over losses of $(3.00) per share from the same period last year. The company reported quarterly sales of $6.62 million which missed the analyst consensus estimate of $13.25 million by 50.01 percent. This is a 1.99K percent increase over sales of $317.00 thousand the same period last year.

Posted In: VBIV


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist